Effects of Sarcopenia on General Health Status in Elderly: a Population-based Study

Sponsor
Universidade do Algarve (Other)
Overall Status
Completed
CT.gov ID
NCT05918159
Collaborator
European Regional Development Fund (Other)
274
1
45.3
6.1

Study Details

Study Description

Brief Summary

This is a observational study, that aimed to determine the prevalence of sarcopenia using European Wording Group on Sarcopenia in Older People (EWGSOP) algorithm in a general elderly population in Algarve region (Portugal). Because muscle is metabolically active tissue, sarcopenia may also contribute to the development of some of the metabolic disorders associated with aging. However, the risk factors associated with sarcopenia are poorly understood. Thus, a cross-sectional survey of a sample of 274 elderly adults aged 60 or over, were included in the study. Correlations of sarcopenia with functional level, lipid and glycemic profile, nutritional and physical activity level, fall risk, quality of life, and self-reported comorbidities will be studied.

Condition or Disease Intervention/Treatment Phase
  • Other: Sarcopenia Assessment

Study Design

Study Type:
Observational
Actual Enrollment :
274 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Effects of Sarcopenia on the Fall Risk, Body Composition, General Health Status and Quality of Life in Elderly: a Population-based Study
Actual Study Start Date :
May 14, 2019
Actual Primary Completion Date :
Feb 20, 2023
Actual Study Completion Date :
Feb 20, 2023

Arms and Interventions

Arm Intervention/Treatment
Elderly

Group of 274 elderly

Other: Sarcopenia Assessment
The prevalence of sarcopenia in a group of elderly people and its correlation with other health variables was determined.

Outcome Measures

Primary Outcome Measures

  1. Prevalence of Sarcopenia in elderly population [0 Months]

    Determine the prevalence of sarcopenia using European Wording Group on Sarcopenia in Older People (EWGSOP) algorithm in a general elderly population in Algarve region.

  2. Quality of life in elderly population [0 Months]

    Quality of life was assessed at one time point only (due to the nature of the cross-sectional study design) using a combination of semi-structured interviews and questionnaire SF-36-v2.

Secondary Outcome Measures

  1. Cognitive Assessment [0 Months]

    Cognitive Assessment was assessed by the instrument Montreal Cognitive Assessment (MoCA).

  2. Body Composition in elderly population [0 Months]

    Body composition was measured using the bioimpedance technique and the body mass index, fat mass, fat-free mass, muscle mass, total body water, resistance, reactance, phase angle and visceral fat were determined.

  3. Lipid Profile in elderly [0 Months]

    Lipid Profile was measured taking a sample blood which was analysed for apolipoproteins HDL, LDL, triglycerides and total cholesterol.

  4. Glicemic Profile in elderly [0 Months]

    Glicemic Profile was measured taking a sample blood which was analysed for Glycated Hemoglobin (HbA1c).

  5. Inflammatory levels in elderly population [0 Months]

    Inflammatory levels was measured taking a sample blood which was analysed for C-reactive protein - CRP.

  6. Nutritional level in elderly population [0 Months]

    Nutrional level was assessed at one time point only (due to the nature of the cross-sectional study design) using a combination of semi-structured interviews and a questionnaire Mini Nutritional Assessment.

  7. Postural Stability in elderly population [0 Months]

    Postural stability was assessed by a force platform using the length displacement of center of pressure.

  8. Isokinetic muscle strength in elderly population [0 Months]

    Isokinetic muscle strength of the quadriceps and hamstrings was measured by afixed dynamometer using peak torque, work, power, peak torque time and force.

  9. Fall risk in elderly population [0 Months]

    Fall risk was assessed by time up and go test and by The Modified Falls Efficacy Scale (MFES).

  10. Physical Activity level in elderly population [0 Months]

    Physical activity level was assessed at one time point only (due to the nature of the cross-sectional study design) using a combination of semi-structured interviews and questionnaire PASE - Physical Activity Scale for Elderly.

  11. Impact of osteoarthritis on pain, stiffness and functionality in elderly population [0 Months]

    Impact of osteoarthritis was assessed at one time point only (due to the nature of the cross-sectional study design) using a combination of semi-structured interviews and the questionnaire Womac Index.

  12. Functional Level of Lower Limbs [0 Months]

    To assess the functionality of the lower limbs, the Lower Extremity Functional Scale (LEFS) instrument was applied.

  13. Handgrip strength (HGS) [0 Months]

    HGS was measured with the handgrip Dynamometer Lafayette Digital 5030D1 in both upper limbs.

  14. Identifies the concerns and priorities of older people [0 Months]

    Following The World Health Organisation ICOPE guidelines, each assessment with ACT Assessment generates a report which lists identifies concerns and priorities for action, together with several summary scores to measure needs, risks and outcomes, including: Quality of life, Falls risk, Vision, Hearing, Activities of Daily Living, Nutrition, Locomotor, Oral Health, Accommodation, Finances, Cognition, Depression, Loneliness, Social participation, and Violence against older people.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Minimum age of 60 years;

  • Live in the community;

  • Independet Gait.

Exclusion Criteria:
  • Presence of moderate or severe cognitive impairment;

  • Presence of uncontrolled cardiovascular disease and active cancer;

  • Use of a pacemaker;

  • Use of internal prosthesis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Marta Botelho Faro Algarve Portugal 8005-139

Sponsors and Collaborators

  • Universidade do Algarve
  • European Regional Development Fund

Investigators

  • Principal Investigator: Sandra R Pais, PhD, Universidade do Algarve

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universidade do Algarve
ClinicalTrials.gov Identifier:
NCT05918159
Other Study ID Numbers:
  • 0348_CIE_6_E_2
First Posted:
Jun 26, 2023
Last Update Posted:
Jun 26, 2023
Last Verified:
Jun 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Universidade do Algarve
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 26, 2023